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Abstract
Background: Tobacco smoking is a major risk factor for many diseases. We sought to quantify the burden of tobacco-
smoking-related deaths in Asia, in parts of which men’s smoking prevalence is among the world’s highest.
Methods and Findings: We performed pooled analyses of data from 1,049,929 participants in 21 cohorts in Asia to quantify
the risks of total and cause-specific mortality associated with tobacco smoking using adjusted hazard ratios and their 95%
confidence intervals. We then estimated smoking-related deaths among adults aged $45 y in 2004 in Bangladesh, India,
mainland China, Japan, Republic of Korea, Singapore, and Taiwan—accounting for ,71% of Asia’s total population. An
approximately 1.44-fold (95% CI = 1.37–1.51) and 1.48-fold (1.38–1.58) elevated risk of death from any cause was found in
male and female ever-smokers, respectively. In 2004, active tobacco smoking accounted for approximately 15.8% (95%
CI = 14.3%–17.2%) and 3.3% (2.6%–4.0%) of deaths, respectively, in men and women aged $45 y in the seven countries/
regions combined, with a total number of estimated deaths of ,1,575,500 (95% CI = 1,398,000–1,744,700). Among men,
approximately 11.4%, 30.5%, and 19.8% of deaths due to cardiovascular diseases, cancer, and respiratory diseases,
respectively, were attributable to tobacco smoking. Corresponding proportions for East Asian women were 3.7%, 4.6%, and
1.7%, respectively. The strongest association with tobacco smoking was found for lung cancer: a 3- to 4-fold elevated risk,
accounting for 60.5% and 16.7% of lung cancer deaths, respectively, in Asian men and East Asian women aged $45 y.
Conclusions: Tobacco smoking is associated with a substantially elevated risk of mortality, accounting for approximately 2
million deaths in adults aged $45 y throughout Asia in 2004. It is likely that smoking-related deaths in Asia will continue to
rise over the next few decades if no effective smoking control programs are implemented.
Please see later in the article for the Editors’ Summary.
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Introduction
Tobacco smoking is a major risk factor for many diseases,
including cardiovascular disease (CVD), respiratory disease, and
cancers of the lung and multiple other sites [1,2]. In the US and
many other Western countries, the epidemic of tobacco smoking
started in men in the early 1900s and reached its peak in the
1960s; a similar epidemic occurred among women,40 y later [3–
5]. The main increase in tobacco-related deaths in these countries
was not seen until the second half of the 20th century [3,6–8]. By
the 1990s, tobacco smoking accounted for an estimated one-third
of all deaths and .50% of cancer deaths in adult men [3,6–8].
With increasing awareness of smoking-associated risks and
heightened anti-smoking campaigns, tobacco use has steadily
declined in the US and many other developed countries over the
past 20–30 y [3–5,9,10], resulting in a recent decrease in lung
cancer and other smoking-related diseases in these countries
[3,11].
In Asia, where ,60% of the world population lives, tobacco
control programs are less well developed, particularly in low- and
middle-income countries including China and India, the two most
populous countries in the world. Inadequate public awareness of
smoking risks, combined with aggressive marketing by tobacco
companies, has resulted in a sharp increase in tobacco smoking
among men in many Asian countries over the past few decades
[3,11,12]. Smoking prevalence in women was traditionally very
low but has increased in recent decades in some Asian countries
[3,11,12]. More than 50% of men in many Asian countries are
smokers [12,13], approximately twice the level in many Western
countries. Despite a recent decline in smoking prevalence in
several high-income Asian countries [11,13], tobacco use in most
Asian countries remains very high. Indeed, Asia is now considered
the largest tobacco producer and consumer in the world. More
than half of the world’s 1.1 billion smokers live in Asia [3,13].
Because many Asian countries are in the early stages of the
tobacco epidemic, it is likely that the burden of diseases caused by
tobacco smoking will continue to rise over the next few decades,
and much longer if the tobacco epidemic remains unchecked.
The size of the effect of tobacco smoking on risk of death,
typically measured using smoking-associated relative risks (RRs),
varies across countries because of differences in characteristics of
smokers, smoking behaviors, and tobacco products. Over the past
15 y, several studies have investigated associations between
smoking and selected health outcomes in certain Asian populations
and have estimated smoking-associated population attributable
risk (PAR) [14–21]. Some studies estimated burden of disease due
to smoking in a specific Asian country/region [14,16,17,19,20].
However, most of these estimates were derived from either a single
cohort study or studies using a less-than-optimal research design.
In this study, we first estimated RRs of overall and cause-specific
mortality associated with tobacco smoking as well as smoking
prevalence, using data from ,1 million participants recruited in
21 prospective cohort studies in seven countries/regions that
account for ,71% of Asia’s total population. We then used these
estimates and mortality data from the World Health Organization
[22] to quantify deaths attributable to tobacco smoking in these
Asian populations.
Methods
This study was approved by the ethics committees for all the
participating studies and of the Fred Hutchinson Cancer Research
Center.
This study utilized resources from a recent pooling project of
prospective cohort studies conducted as part of the Asia Cohort
Consortium that quantified the association between body mass
index and risk of overall and cause-specific mortality in Asians
[23]. Cohorts included in the current analysis were in Bangladesh,
India, mainland China, Japan, Republic of Korea, Singapore, and
Taiwan. A brief description of each of the participating cohort
studies is provided in Text S1. All of the cohort studies collected
baseline data on demographics, lifestyle factors, body mass index,
and history of tobacco smoking, which included current smoking
status, duration, and amount and types of tobacco products. Data
on all-cause and cause-specific mortality were ascertained through
linkage to death certificate data or active follow-up. Additional
data were collected on other baseline variables, including
education, marital status, alcohol consumption, physical activity,
and previous diagnosis of selected diseases, including diabetes,
hypertension, cancer, and CVDs. Individual-level data from all
participating cohorts were collected and harmonized for statistical
analysis.
The association between tobacco smoking and risk of death was
examined using Cox proportional hazards regression models,
employing a categorical representation of tobacco smoking as the
predictor variable. Lifetime nonsmokers were used as the reference
for estimating hazard ratios (HRs)—as measures of RR of death
for the exposed versus the non-exposed population—and 95%
confidence intervals associated with ever, former, and current
smoking, as well as pack-years smoked, after adjusting for potential
confounders including baseline age, education, urban/rural
residence, body mass index, and marital status. All analyses were
conducted separately for men and women because of large
differences in smoking prevalence. Analyses were country-specific
unless otherwise noted. To improve the stability of point estimates
in the analyses of pack-years of smoking and for risk of death due
to site-specific cancer, as well as types of CVD and respiratory
diseases, cohorts were combined into broad ethnic groupings:
South Asians (Indians and Bangladeshis) and East Asians (Chinese
[including cohorts from mainland China, Singapore, and
Taiwan], Japanese, and Koreans), and categorized further among
East Asians into Chinese/Koreans and Japanese. No smoking-
associated HR was estimated for Bangladesh separately because of
the small sample size. The number of Koreans in this study was
small, and, thus, they were combined with Chinese individuals in
some analyses. Bidi smoking is common in India and Bangladesh;
thus, information regarding bidi smoking was incorporated to
construct smoking variables, including pack-years smoked (4
bidis = 1 cigarette based on approximately 0.25 and 1.0 g of
tobacco per bidi and cigarette, respectively).
In the models, the effect of tobacco smoking on mortality was
assumed to be cohort-specific. For each cohort, we assumed that
the log-HR for tobacco smoking has a fixed-effect component that
is common to all cohorts within each country and a random effect
that is cohort-specific. Random effects for log-HRs were assumed
to be normally distributed, with mean zero; that is, we assumed
that b^ij , the estimated log-HR for the j-th smoking level in the i-th
cohort, has distribution b^ij*N bj ,s^
2
ijzt
2
j
 
, where s^2ij is the
within-study variance of b^ij as estimated from the Cox regression
model and t2j is the between-cohort variance of b^ij [24,25].
Parameter bj and 95% CIs were estimated in the meta-analysis.
Age at study entry and exit was used to define the time-to-event
variable in the Cox models. Age at study exit was defined as age at
date of death or end of follow-up, whichever occurred first. Cox
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model estimation for each cohort was performed using the
PHREG procedure in SAS version 9.2. Meta-analysis estimation
was performed using the SAS MIXED procedure.
To estimate PAR, we used the following formula:
PAR=P(RR21)/[P(RR21)+1], where smoking prevalence and
smoking-associated RR are denoted as P and RR (measured using
HR in this analysis), respectively. PARs for overall mortality and
major causes of death associated with tobacco smoking were
estimated for each cohort and then combined using meta-analyses
to derive summary PARs per country. To estimate PARs for East
Asians (Chinese, Japanese, and Koreans), South Asians (Bangla-
deshis and Indians), or all seven countries/regions combined, we
used the population size of each country/region as a weight to
derive weighted HR and smoking prevalence values. To estimate
the number of deaths attributable to tobacco smoking, we used
World Health Organization age-specific death rates for 2004 for
each country. Most of the cohort studies enrolled participants after
the mid-1980s; therefore, smoking prevalence rates estimated in
this study reflect smoking status in the 1990s (Table 1). Given the
long latency of chronic diseases—typically 15 y and longer—it is
reasonable to use smoking prevalence rates assessed in the 1990s to
estimate number of deaths due to tobacco smoking in 2004.
The number of deaths from a particular disease attributable to
tobacco smoking was calculated by multiplying the PAR for that
disease by the total number of deaths in the population from that
disease. Analyses also were performed to estimate the number of
deaths from a particular disease due to smoking for age groups 45–
59, 60–69, and $70 y using age-specific HRs and smoking
prevalence and then summing these age-specific estimates to
obtain the overall number of deaths due to smoking for that
disease. This age-specific method yielded similar results to the one
without age-specific estimates, and, thus, the latter method was
used, as it provides a tighter 95% CI than the age-specific method.
Results
A total of 1,223,092 participants were included in the 21
participating cohorts for this study. Because most studies were
conducted among adults aged $45 y, participants (n=70,812)
who did not contribute person-years in the age group $45 y were
excluded from this analysis. Also excluded (not mutually exclu-
sively) were participants with prior history of cancer or CVD at
baseline (n=47,585), with missing data on tobacco smoking
(n=38,898) or vital status (n=451), or with less than 1 y of
observation after baseline survey (n=30,039). After these exclu-
sions, 1,049,929 participants (510,261 men; 539,668 women)
remained (Table 1). Overall, the mean prevalence of tobacco
smoking was 65.1% for men and 7.1% for women. Over a mean
follow-up of 10.2 y through roughly the mid-2000s for most
cohorts, a total of 123,975 deaths were identified in these cohorts.
Compared with never-smokers, a 1.44-fold higher risk (95%
CI= 1.37–1.51) of deaths from all causes was observed among
male ever-smokers in pooled analyses of all cohorts (Table 2). The
estimated HRs related to smoking were slightly higher in
Singapore, Republic of Korea, Japan, and Taiwan than in India
and mainland China, although 95% CIs overlapped in some of
these point estimates (heterogeneity test: p,0.001, I2 = 89 [95%
CI= 85–92]). Among women, ever smoking was associated with a
1.48-fold higher risk (95% CI= 1.38–1.58) of death from any
cause. This risk also varied across study populations (heterogeneity
test: p,0.001, I2 = 82 [95% CI= 74–88]). The lowest elevation of
risk was observed among Indian women, in which ever smoking
was related to a 1.16-fold (95% CI= 0.98–1.36) elevated risk of
deaths from all causes. Elevated risk of death was also seen among
former smokers, although the risk was lower than among current
smokers (Table S1).
Among men, elevated risk of death due to CVD, cancer, and
respiratory diseases was statistically significantly associated with
ever smoking in virtually all study populations (Table 3). Ever
smoking was associated with a 1.35-fold elevated risk (95%
CI= 1.26–1.45) of death due to CVD in the analysis that included
all cohorts. The risk, however, varied considerably across
populations, with the strongest association observed in Taiwan
(HR=1.69; 95% CI= 1.36–2.10) and the weakest association
observed in mainland China (HR=1.17; 95% CI= 1.11–1.25)
(heterogeneity test: p,0.001, I2 = 77 [95% CI= 66–85]). A 1.75-
fold elevated risk (95% CI= 1.67–1.85) of death due to cancer in
men was associated with ever smoking in the combined analysis of
all cohorts. The association with cancer risk was, in general, quite
consistent across study populations (heterogeneity test: p=0.76).
For death due to respiratory diseases in men, a 1.53-fold elevated
risk (95% CI=1.39–1.69) was associated with ever smoking in the
combined analysis of all cohorts, and no statistically significant
heterogeneity was identified (p=0.29). Among East Asian women,
positive associations were also observed between ever smoking and
risk of major cause-specific deaths, with HRs ranging from 1.44
(95% CI= 1.23–1.69) for respiratory diseases to 1.59 for CVD
(95% CI=1.41–1.79) and cancer (95% CI= 1.45–1.75). Hetero-
geneity tests were statistically significant for cancer (p,0.001) and
respiratory diseases (p=0.003) but not for CVD (p=0.20). Some of
the country-specific risk estimates for East Asian women were not
statistically significant because of low smoking prevalence among
women in Asia. Among Indian women and all South Asian
women combined, the association between ever smoking and risk
of cause-specific deaths was weak and statistically nonsignificant.
To quantify risk associated with smoking status and pack-years
of smoking, we combined cohorts by ethnic background to
improve the stability of point estimates. For men (Table 4) and
women (Table 5), risk of total mortality and cause-specific
mortality was elevated with increased tobacco smoking among
current smokers, measured by pack-years of smoking. Excess
deaths were also observed among former smokers, compared with
never-smokers, although the risk was lower than for current
smokers for deaths due to any cause, CVD, and cancer. A
substantially elevated risk of death from respiratory diseases was
found among former smokers, particularly in Chinese/Koreans
and Indians/Bangladeshis. This excess is probably caused by some
smokers quitting smoking after they developed respiratory
diseases. Risks associated with smoking status and pack-years of
smoking were not estimated for South Asian women because of the
small sample size.
Further analyses were performed to estimate smoking-associated
HRs for selected cancers as well as for other common diseases
(Table 6). Among men and women, the strongest association with
tobacco smoking was lung-cancer mortality: a 3- to 4-fold elevated
risk consistently across all populations. In East Asian men, ever
smoking was also associated with elevated risk for cancers of the
mouth/pharynx/larynx, esophagus, stomach, colorectum, liver,
pancreas, and bladder, cancers that have been consistently related
to smoking in previous studies. HR estimates for South Asians
were statistically nonsignificant or unreliable for several cancers,
probably because of small sample sizes. Because of the relatively
small sample size of female ever-smokers in South Asia, results are
presented for East Asian women only. As in men, risks were
elevated for virtually all smoking-related cancers.
Among East Asian men and women, risks of death associated
with smoking were elevated for coronary heart disease, stroke, and
chronic obstructive pulmonary disease. Among South Asian men,
Tobacco Smoking & Risk of Death in Asian Populations
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the association was statistically significant for coronary heart
disease and chronic obstructive pulmonary disease but not for
stroke. Smoking was associated with elevated risk of death due to
tuberculosis in South Asians. However, no association between
smoking and tuberculosis was found in East Asians.
Among men $45 y, approximately 15.8% (95% CI= 14.3%–
17.2%) of deaths (1.34 million [95% CI= 1.21–1.46 million]) from
all causes in 2004 were attributable to tobacco smoking in these
seven countries/regions combined (Table 7). Smoking-associated
PARs for all-cause mortality were higher in Japan (27.7%),
Republic of Korea (26.9%), and Singapore (24.8%) than in
mainland China (16.2%), India (11.5%), Taiwan (19.7%), and
Bangladesh (14.3%). Among women $45 y, tobacco smoking
accounted for ,3.3% (95% CI= 2.6%–4.0%) of total deaths
(239,000 [95% CI= 188,300–289,700]) in the seven countries/
regions combined in 2004.
Among men aged $45 y, ,11.4% (95% CI= 9.1%–13.8%),
30.5% (95% CI = 27.4%–33.6%), and 19.8% (95% CI= 14.8%–
24.8%) of deaths due to CVD, cancer, and respiratory diseases,
respectively, were attributable to tobacco smoking in 2004
(Table 8). Smoking-associated PARs for cause-specific mortality
were also higher, in general, in Japan, Republic of Korea, and
Singapore than in the other study populations. Overall, 60.5%
(95% CI= 54.5%–66.4%) of lung cancer deaths in men were
attributable to tobacco smoking. Data for women are presented
for mainland China, Japan, and all East Asians combined,
because of the small sample size for other groups. Smoking-
associated PARs were much smaller in women than in men: 1.7%
(95% CI= 0%–4.0%), 3.7% (95% CI= 2.4%–5.0%), and 4.6%
(95% CI= 3.3%–5.8%) for deaths due to respiratory diseases,
CVD, and cancer, respectively. Nevertheless, ,16.7% (95%
CI= 13.3%–20.0%) of lung-cancer deaths in East Asian women
$45 y were attributable to tobacco smoking in 2004.
Discussion
Similar to studies conducted in Europe and North America [1–
5,9,10], we found that tobacco smoking is associated with
Table 2. Association of tobacco smoking with risk of death from all causes in selected study populations in Asia.
Population Men Women
Number of
Participants
Number of
Deaths HR (95% CI)a
Number of
Participants
Number
of Deaths HR (95% CI)a
All cohorts combined
Never smoker 177,956 19,353 1.00 501,246 43,067 1.00
Ever smoker 332,305 54,822 1.44 (1.37, 1.51) 38,422 6,733 1.48 (1.38, 1.58)
India
Never smoker 68,866 6,613 1.00 104,223 6,880 1.00
Ever smoker 49,530 6,554 1.31 (1.26, 1.36) 1,378 198 1.16 (0.98, 1.36)
Mainland China
Never smoker 48,664 4,797 1.00 126,085 6,945 1.00
Ever smoker 91,519 9,036 1.30 (1.25, 1.35) 11,154 1,417 1.36 (1.28, 1.45)
Taiwan
Never smoker 5,830 647 1.00 13,696 1,103 1.00
Ever smoker 7,463 1,344 1.44 (1.30, 1.58) 142 17 1.41 (0.85, 2.33)
Singapore
Never smoker 10,875 1,357 1.00 29,645 2,786 1.00
Ever smoker 14,470 3,399 1.58 (1.48, 1.68) 2,724 692 1.75 (1.60, 1.92)
Republic of Korea
Never smoker 4,153 220 1.00 7,567 330 1.00
Ever smoker 14,565 1,180 1.47 (1.26, 1.72) 841 105 1.36 (1.07, 1.73)
Japan
Never smoker 39,108 5,700 1.00 218,448 24,997 1.00
Ever smoker 152,519 33,162 1.49 (1.42, 1.55) 21,892 4,290 1.50 (1.38, 1.63)
East Asiansb
Never smoker 108,630 12,721 1.00 395,441 36,161 1.00
Ever smoker 280,536 48,121 1.46 (1.39, 1.54) 36,753 6,521 1.50 (1.40, 1.61)
South Asiansc
Never smoker 69,326 6,632 1.00 105,805 6,906 1.00
Ever smoker 51,769 6,701 1.31 (1.26, 1.36) 1,669 212 1.18 (1.01, 1.38)
aAdjusted for age, education, rural/urban resident, marital status, and body mass index; data from participants with ,1 y of follow-up are excluded.
Analyses were conducted among those age 45 y or older.
bIncluding data from mainland China, Taiwan, Singapore, Republic of Korea, and Japan.
cIncluding data from India and Bangladesh.
doi:10.1371/journal.pmed.1001631.t002
Tobacco Smoking & Risk of Death in Asian Populations
PLOS Medicine | www.plosmedicine.org 6 April 2014 | Volume 11 | Issue 4 | e1001631
substantially elevated risk of total and cause-specific mortality.
This study analyzed individual-level data from seven Asian
countries/regions, using a uniform analytic approach, which
enabled comparisons of smoking-associated HRs and PARs across
these countries/regions. This study provides strong evidence that
tobacco smoking is a major cause of death in Asia and underscores
the importance and urgency of implementing comprehensive
tobacco control programs for disease prevention in this populous
continent.
Most smoking-associated RR estimates in this study were 1.3–
1.5 for all-cause mortality, comparable to most estimates from
previous studies conducted in Asia [14–21]. These RRs, however,
are substantially lower than those from studies conducted in
Europe and North America, where .2-fold elevated risk for all-
cause mortality is typically reported for current smokers [1–
3,5,9,10]. Among specific causes of mortality evaluated in this
study, lung cancer showed the strongest association with tobacco
smoking, with estimated HRs of 3.0 to 4.0, approximately one-
third of the risk observed in most studies conducted in Western
countries [1–3,5,9,10]. The smaller effect of smoking on mortality
in Asia compared with Western countries could be partly
explained by the fact that widespread tobacco smoking in most
Asian countries began several decades later than in Europe and
North America, and thus many Asian countries are still in the
early stages of a tobacco epidemic; many smokers in the
population started smoking tobacco at a late age and smoke a
small number of cigarettes daily [3,12]. In the British Doctors
Study, a 1.6-fold elevated risk of all-cause mortality was observed
among smokers in early years of follow-up (1951–1971) [26], close
to the effect size estimated in this study. In later follow-up (1971–
1991), the RR rose to 2.1. A recent Japanese study showed a clear
birth-cohort effect: male smokers born before 1890 started
smoking at a later age and smoked fewer cigarettes daily than
those born in 1940–1945 [27]. As a result, the association of
smoking with risk of all-cause mortality was weaker in the older
cohort (RR=1.24) than the younger cohort (RR=1.92). Our
study showed a clear dose–response relationship between pack-
years of smoking and risk of all-cause and cause-specific mortality.
It is likely that, with maturation of the tobacco epidemic in Asia
and lack of effective tobacco control, more smokers will
accumulate much higher pack-years of smoking, and, thus,
smoking-associated RRs will rise, mirroring the trend in the US
and Europe.
Several previous studies have estimated the burden of disease
due to tobacco smoking in a specific Asian country/region
[14,16,17,19,20] (Table S2). However, most previous estimates for
smoking-associated RRs and PARs were derived from either a
single cohort study [14,19] or a retrospective case–control study
[16–18]. Not all previous studies had detailed demographic and
risk-factor information to adequately adjust for potential con-
founders when estimating risks. Three previous studies conducted
in mainland China and Taiwan provided somewhat lower
Table 3. Association of tobacco smoking with risk of death from cardiovascular diseases, cancer, or respiratory diseases in selected
study populations in Asia.
Population CVD Cancer Respiratory Diseases
Number of Deathsa HR (95% CI)b Number of Deathsa HR (95% CI)b Number of Deathsa HR (95% CI)b
Men
All cohorts combined 15,381/6,526 1.35 (1.26, 1.45) 17,049/3,818 1.75 (1.67, 1.85) 5,671/1,764 1.53 (1.39, 1.69)
India 2,183/2,275 1.27 (1.18, 1.36) 663/379 1.84 (1.59, 2.13) 825/615 1.50 (1.33, 1.69)
Mainland China 3,378/2,055 1.17 (1.11, 1.25) 3,195/1,227 1.72 (1.60, 1.85) 619/326 1.36 (1.18, 1.57)
Taiwan 291/121 1.69 (1.36, 2.10) 488/208 1.63 (1.38, 1.93) 111/43 1.59 (1.09, 2.32)
Singapore 1,050/476 1.43 (1.28, 1.60) 1,313/451 1.85 (1.66, 2.07) 591/190 1.79 (1.51, 2.13)
Republic of Korea 200/43 1.27 (0.90, 1.80) 543/92 1.66 (1.32, 2.10) 72/11 1.67 (0.82, 3.40)
Japan 8,208/1,544 1.35 (1.27, 1.43) 10,825/1,460 1.77 (1.67, 1.88) 3,437/579 1.55 (1.41, 1.70)
East Asiansc 13,127/4,239 1.38 (1.28, 1.49) 16,364/3,438 1.75 (1.66, 1.84) 4,830/1,149 1.54 (1.38, 1.72)
South Asiansd 2,254/2,287 1.26 (1.18, 1.35) 685/380 1.85 (1.59, 2.17) 841/615 1.50 (1.33, 1.69)
Women
All cohorts combined 2,552/13,837 1.54 (1.36, 1.73) 1,752/9,971 1.58 (1.44, 1.74) 655/3,760 1.40 (1.20, 1.63)
India 59/2,316 1.04 (0.77, 1.40) 13/587 1.18 (0.66, 2.10) 29/814 1.05 (0.68, 1.62)
Mainland China 666/2,687 1.48 (1.35, 1.62) 344/1,827 1.56 (1.37, 1.77) 63/323 1.18 (0.89, 1.58)
Taiwan 4/235 1.73 (0.64, 4.71) 12/399 2.94 (1.59, 5.42) 0/63 —e
Singapore 230/969 1.50 (1.28, 1.75) 262/992 2.19 (1.90, 2.54) 112/323 2.13 (1.70, 2.67)
Republic of Korea 35/113 1.24 (0.83, 1.88) 18/79 1.46 (0.83, 2.57) 8/22 1.34 (0.54, 3.31)
Japan 1,511/7,502 1.63 (1.37, 1.95) 1,102/6,083 1.49 (1.39, 1.59) 441/2,212 1.40 (1.26, 1.56)
East Asiansc 2,486/11,506 1.59 (1.41, 1.79) 1,738/9,380 1.59 (1.45, 1.75) 624/2,943 1.44 (1.23, 1.69)
South Asiansd 66/2,331 1.07 (0.81, 1.43) 14/591 1.16 (0.66, 2.04) 31/817 1.05 (0.69, 1.61)
aNumber of deaths among ever-smokers/never-smokers are presented.
bAdjusted for age, education, rural/urban resident, marital status, and body mass index; data from participants with ,1 y of follow-up are excluded.
Analyses were conducted among those age 45 y or older.
cIncluding data from mainland China, Taiwan, Singapore, Republic of Korea, and Japan.
dIncluding data from India and Bangladesh.
eHR not estimated because of small sample size.
doi:10.1371/journal.pmed.1001631.t003
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estimates of total male deaths due to smoking than our estimates,
perhaps because these studies were conducted during even earlier
stages of the tobacco epidemic in these populations, resulting in
smaller PARs [14,16,19]. For India, however, the estimate of male
deaths attributable to tobacco smoking from a previous study (20%
of total male deaths) [17] was substantially higher than the
estimate from our study (11.5% of total male deaths). To our
knowledge, no study has been previously conducted in Bangla-
desh, the Republic of Korea, or Singapore; thus, our study
provides, for the first time, direct estimates of deaths due to
tobacco smoking in these countries. Despite methodological
differences between this and previous studies, all studies conducted
to date have shown that an alarming proportion of deaths are
caused by tobacco smoking.
In this study, some estimates among women are unstable
because of very low smoking prevalence. Although not all
participating cohorts are representative of the general popu-
lation, smoking-associated RRs estimated in this study, are, in
general, comparable to those from previous studies. Further-
more, smoking-associated RRs estimated in multiple cohorts
within the same country are, in general, comparable. It is
difficult to find national survey data consistent with the
definitions, time period, and age groups of our study for all
seven countries/regions in our analysis. Many national surveys
used a smaller sample than our study, providing unstable
smoking prevalence estimates. Therefore, we chose to use
smoking prevalence estimates from our own study to estimate
PARs: smoking-associated RRs were estimated based on
exposure history of the same group of individuals, which
should provide better estimates of disease burden due to
tobacco smoking in the study population than using data from
external sources. Smoking prevalence has declined recently in
several high-income Asian countries. However, given the long
latency of chronic diseases, typically 15 y and longer, it is
reasonable to use smoking prevalence rates assessed in the
1990s to estimate number of deaths due to tobacco smoking in
2004. As most of the cohort studies included in this study were
conducted among adults aged $45 y, we were unable to
estimate the impact of active tobacco smoking in people
younger than 45 y old. Again, because of the long latency of
chronic diseases, most of the smoking-related diseases tend to
occur later in life.
We estimated smoking-associated PARs and numbers of deaths
due to tobacco smoking in 2004. As many Asian countries, such as
China and India, are still in the early stage of tobacco epidemics,
the number of deaths due to tobacco smoking in more recent years
in these countries is likely to be larger than that estimated in this
study.
Data on secondhand tobacco-smoke exposure was not
available in this study. Secondhand smoke has been linked to
an elevated risk of multiple chronic diseases [2,28,29]. It has
been estimated that approximately 603,000 deaths worldwide
may be due to secondhand smoke [29]. We also were unable to
evaluate smokeless tobacco, a risk factor for oral cancer and
several other chronic diseases [30,31]. Smokeless tobacco use is
common in India and Bangladesh, especially among women in
these countries. Some individuals who had secondhand
tobacco-smoke exposure or used smokeless tobacco may be
included in the reference group, which may result in an
underestimate of the risk associated with active tobacco
smoking. Furthermore, in our study, RRs associated with
tobacco smoking were estimated primarily based on the time
period from the early 1990s to the mid-2000s. Because
smoking-associated risk of death is likely to increase with the
maturation of the tobacco epidemic, the total number of
deaths due to smoking in 2004 may be underestimated using
Table 7. Smoking prevalence, population attributable risk, and number of deaths due to tobacco smoking in selected Asian
populations.
Population Men Women
Smoking
Prevalence
(Percent) PAR (Percent)
Number of
Deaths
(in Thousands)
Smoking
Prevalence
(Percent) PAR (Percent)
Number of
Deaths
(in Thousands)
Bangladesh 53.8a 14.3 (12.2, 16.4)b 46.4 (39.6, 53.3) 3.0a 0.5 (0.0, 1.1)b 1.5 (0, 3.4)
India 41.8 11.5 (9.8, 13.2) 378.8 (322.8, 434.8) 1.3 0.2 (0.0, 0.4) 6.9 (0, 11.0)
Mainland China 65.3 16.2 (14.0, 18.5) 675.7 (583.9, 771.6) 8.1 2.9 (2.2, 3.5 104.6 (79.4, 126.3)
Taiwanc 56.1 19.7 (14.6, 24.7) 18.4 (13.6, 23.0) 4.2a 1.7 (0.0, 4.6) 1.0 (0, 2.7)
Singapore 57.1 24.8 (21.4, 28.1) 2.5 (2.1, 2.8) 8.4 6.0 (4.8, 7.1) 0.5 (0.4, 0.6)
Republic of Korea 77.8 26.9 (17.6, 36.3) 37.8 (24.8, 51.1) 6.1a 2.1 (0.2, 4.0) 2.4 (0.2, 4.5)
Japan 79.6 27.7 (25.9, 29.5) 143.7 (134.3, 153.0) 9.1 3.7 (3.3, 4.2) 16.8 (15.0, 19.1)
East Asiansd 67.3 18.0 (15.9, 20.1) 869.4 (768.0, 970.9) 8.1 2.9 (2.0, 3.9) 122.8 (84.7, 165.1)
South Asiansd 42.8 11.7 (10.0, 13.4) 424.6 (362.9, 486.3) 1.6 0.3 (0.0, 0.6) 9.2 (0, 18.4)
All populationsd 58.6 15.8 (14.3, 17.2) 1,336.5 (1,209.7, 1,455.0) 5.8 3.3 (2.6, 4.0) 239.0 (188.3, 289.7)
Estimates are provided for populations age 45 y or older.
aBecause of the small sample size in the current study for these populations, data for smoking prevalence rates were obtained from other sources: Bangladeshi men and
women: [12], Taiwanese women: [19], and Korean women: [34].
bPARs were estimated using HRs derived from all South Asian cohorts combined because of unstable HR estimates using Bangladeshi data alone.
cMortality data for Taiwan were obtained from http://www.mohw.gov.tw/CHT/Ministry/Index.aspx.
dPARs were estimated using weighted HRs and smoking prevalence of the study populations.
Thus, the number of deaths attributable to smoking in these populations may not be equal to the sum of the numbers of deaths from the countries in the population
areas. East Asia: mainland China, Taiwan, Singapore, Republic of Korea, and Japan. South Asia: Bangladesh and India. All populations: all seven countries/regions listed
above.
doi:10.1371/journal.pmed.1001631.t007
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this set of RRs. Therefore, the true impact of tobacco smoking
on mortality in these Asian countries is likely to be even larger
than estimated here. Despite some limitations mentioned
above, our study provides perhaps the best estimates of
tobacco-associated deaths to date in these Asian countries/
regions.
Over the past 50 years, the landscape of tobacco smoking has
changed dramatically around the world. Smoking prevalence has
declined sharply in many high-income countries, resulting in a
recent decrease in smoking-related deaths, particularly among
men [3,8]. Conversely, prevalence of tobacco use remains high in
China, India, and other low- and middle-income countries. As
the tobacco epidemic grows in these countries, we anticipate that
an increasing number of deaths will be attributable to tobacco
smoking in Asia in the coming years. Even in more well-
developed Asian countries such as Japan and Republic of Korea,
where smoking rates have recently declined, the full impact of
tobacco smoking on mortality is unlikely to be seen soon because,
as noted above, smokers in recent birth cohorts tend to smoke
more and start smoking earlier, elevating their risk of smoking-
associated deaths, and because of the long latency of the diseases
associated with smoking, these deaths will not accrue immedi-
ately. Our study shows that tobacco smoking is a major cause of
death in Asia, accounting for ,1.6 million deaths of adults $45 y
in 2004 in the seven countries/regions in this analysis. If the
remaining 29% of the Asian population is experiencing a tobacco
epidemic similar to that of these seven countries/regions, we
estimate that, in 2004, .2 million deaths in Asia were
attributable to tobacco smoking. Thus, of the 5 million deaths
currently attributable to active tobacco smoking worldwide [32],
nearly 45% occur in Asia. Our study provides sobering evidence
that stresses the urgency of implementing comprehensive tobacco
control programs in Asia, as recommended by the WHO
Framework Convention on Tobacco Control [33]. Tobacco
control should be among the top priorities in Asia to reduce the
burden of disease.
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Editors’ Summary
Background. Every year, more than 5 million smokers die
from tobacco-related diseases. Tobacco smoking is a major
risk factor for cardiovascular disease (conditions that affect
the heart and the circulation), respiratory disease (conditions
that affect breathing), lung cancer, and several other types of
cancer. All told, tobacco smoking kills up to half its users. The
ongoing global ‘‘epidemic’’ of tobacco smoking and tobac-
co-related diseases initially affected people living in the US
and other Western countries, where the prevalence of
smoking (the proportion of the population that smokes) in
men began to rise in the early 1900s, peaking in the 1960s. A
similar epidemic occurred in women about 40 years later.
Smoking-related deaths began to increase in the second half
of the 20th century, and by the 1990s, tobacco smoking
accounted for a third of all deaths and about half of cancer
deaths among men in the US and other Western countries.
More recently, increased awareness of the risks of smoking
and the introduction of various tobacco control measures
has led to a steady decline in tobacco use and in smoking-
related diseases in many developed countries.
Why Was This Study Done? Unfortunately, less well-
developed tobacco control programs, inadequate public
awareness of smoking risks, and tobacco company market-
ing have recently led to sharp increases in the prevalence of
smoking in many low- and middle-income countries,
particularly in Asia. More than 50% of men in many Asian
countries are now smokers, about twice the prevalence in
many Western countries, and more women in some Asian
countries are smoking than previously. More than half of the
world’s billion smokers now live in Asia. However, little is
known about the burden of tobacco-related mortality
(deaths) in this region. In this study, the researchers quantify
the risk of total and cause-specific mortality associated with
tobacco use among adults aged 45 years or older by
undertaking a pooled statistical analysis of data collected
from 21 Asian cohorts (groups) about their smoking history
and health.
What Did the Researchers Do and Find? For their
study, the researchers used data from more than 1 million
participants enrolled in studies undertaken in Bangla-
desh, India, mainland China, Japan, the Republic of Korea,
Singapore, and Taiwan (which together account for 71%
of Asia’s total population). Smoking prevalences among
male and female participants were 65.1% and 7.1%,
respectively. Compared with never-smokers, ever-smok-
ers had a higher risk of death from any cause in pooled
analyses of all the cohorts (adjusted hazard ratios [HRs] of
1.44 and 1.48 for men and women, respectively; an
adjusted HR indicates how often an event occurs in one
group compared to another group after adjustment for
other characteristics that affect an individual’s risk of the
event). Compared with never smoking, ever smoking was
associated with a higher risk of death due to cardiovas-
cular disease, cancer (particularly lung cancer), and
respiratory disease among Asian men and among East
Asian women. Moreover, the researchers estimate that, in
the countries included in this study, tobacco smoking
accounted for 15.8% of all deaths among men and 3.3%
of deaths among women in 2004—a total of about 1.5
million deaths, which scales up to 2 million deaths for the
population of the whole of Asia. Notably, in 2004,
tobacco smoking accounted for 60.5% of lung-cancer
deaths among Asian men and 16.7% of lung-cancer
deaths among East Asian women.
What Do These Findings Mean? These findings provide
strong evidence that tobacco smoking is associated with
a substantially raised risk of death among adults aged 45
years or older throughout Asia. The association between
smoking and mortality risk in Asia reported here is weaker
than that previously reported for Western countries,
possibly because widespread tobacco smoking started
several decades later in most Asian countries than in
Europe and North America and the deleterious effects of
smoking take some years to become evident. The
researchers note that certain limitations of their analysis
are likely to affect the accuracy of its findings. For
example, because no data were available to estimate the
impact of secondhand smoke, the estimate of deaths
attributable to smoking is likely to be an underestimate.
However, the finding that nearly 45% of the global deaths
from active tobacco smoking occur in Asia highlights the
urgent need to implement comprehensive tobacco
control programs in Asia to reduce the burden of
tobacco-related disease.
Additional Information. Please access these websites via
the online version of this summary at http://dx.doi.org/10.
1371/journal.pmed.1001631.
N The World Health Organization provides information about
the dangers of tobacco (in several languages) and about
the WHO Framework Convention on Tobacco Control, an
international instrument for tobacco control that came
into force in February 2005 and requires parties to
implement a set of core tobacco control provisions
including legislation to ban tobacco advertising and to
increase tobacco taxes; its 2013 report on the global
tobacco epidemic is available
N The US Centers for Disease Control and Prevention
provides detailed information about all aspects of
smoking and tobacco use
N The UK National Health Services Choices website provides
information about the health risks associated with
smoking
N MedlinePlus has links to further information about the
dangers of smoking (in English and Spanish)
N SmokeFree, a website provided by the UK National Health
Service, offers advice on quitting smoking and includes
personal stories from people who have stopped smoking
N Smokef ree .gov , from the US National Cancer
Institute, offers online tools and resources to help people
quit smoking
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